title: Update in perioperative cardiac medicine.
abstract: Recent studies have shed light on preoperative risk assessment, medical therapy to reduce postoperative cardiac complications (beta-blockers, statins, and angiotensin II receptor blockers [ARBs]), perioperative management of patients with coronary stents on antiplatelet therapy, and perioperative bridging anticoagulation.
authors.affiliation: Medical Director, UHealth Preoperative Assessment Center, Miami, FL, USA.|Director, Medical Consultation Services, University of Miami Hospital/Jackson Memorial Hospital, Miami, FL, USA.|Professor of Clinical Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. E-mail: scohn@med.miami.edu.
authors.forename: Steven L
authors.initials: SL
authors.lastname: Cohn
authors.affiliation: Assistant Professor, Rush University Medical Center, Chicago, IL, USA.|Associate Division Chief, Division of Hospital Medicine, and Medical Director, Attending Directed Service, Rush University Medical College, Chicago, IL, USA.
authors.forename: Suparna
authors.initials: S
authors.lastname: Dutta
authors.affiliation: Professor of Medicine and Orthopedic Surgery, Milwaukee, WI, USA.|Chief, Section of Perioperative and Consultative Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Slawski
authors.affiliation: Assistant Professor of Medicine and Director, Perioperative and Consultative Medicine, Division of General Medicine, University of Michigan Health System, Ann Arbor, MI, USA.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Grant
authors.affiliation: Professor of Medicine, Harvard Medical School, Boston, MA, USA.|Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.
authors.forename: Gerald W
authors.initials: GW
authors.lastname: Smetana
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D019990:Perioperative Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000925:Anticoagulants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors